Yttrium-90 (Y-90) radioembolization continues to be used in the treatment of colorectal cancer liver metastases (CRLMs), despite the lack of improvement in overall survival (OS) in randomized trials.

Patients with androgen-independent PC and evidence of disease progression received indium-111–J591 for pharmacokinetic and biodistribution determinations followed 1 week later by 90 Y-J591 at five ...

May 3, 2009 (Copenhagen, Denmark) — A phase 2 study of radioembolization with yttrium-90 has shown it to be effective and safe for the treatment of advanced hepatocellular carcinoma (HCC), with or ...

INDIANAPOLIS -- The latest weapon against inoperable liver cancer is so tiny that it takes millions of them per treatment, but according to interventional radiologists at the Indiana University School ...

March 19, 2010 (Tampa, Florida) — An interventional radiology treatment using intra-arterial yttrium-90 (Y-90) microspheres (TheraSphere, MDS Nordion) shows promise in prolonging life for patients ...

A minimally invasive treatment that delivers cancer-killing radiation directly to tumors shows promise in treating breast cancer that has spread to the liver when no other treatment options remain.

Tiverton, Ontario, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Bruce Power announced today that it has entered into a Memorandum of Understanding (MOU) with Boston Scientific to explore the feasibility of ...

My father has had chronic liver disease. Recently, he was diagnosed with liver cancer. His doctor mentioned Y-90 as one treatment option. What is Y-90, and is it safe? The gold standard of therapy for ...

Interventional radiologists have been the leaders in the use of intra-arterial yttrium-90 radioembolization, since its introduction in 2000, to treat liver cancer. Now, new results from a large ...

Nicosia, Cyprus, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that one of the acquisition companies of the ...